
About Dr. Naser Alzein
Dr. Naser Alzein is a highly experienced Paediatric Haematologist and Oncologist with over 30 years of clinical experience. He is double American Board certified in Paediatrics and Paediatric Haematology and Oncology.
Dr. Alzein specialises in treating childhood cancers, blood disorders, leukaemia, solid tumours, and patients undergoing bone marrow transplantation. He combines advanced medical expertise with a compassionate approach, providing personalised care and support to children and their families throughout treatment.
Why Choose Dr. Naser Alzein?
- International Experience: Has held senior leadership roles, including Medical Director of Paediatric Haematology and Oncology at Blank Children's Hospital, USA, and Chairman of Paediatrics at Sheikh Khalifa Medical City (SKMC), Abu Dhabi.
- Double American Board Certified: Certified by the American Board of Pediatrics (ABP) in both General Paediatrics and Paediatric Haematology and Oncology.
- Award-Winning Researcher: Received the American Society of Clinical Oncology (ASCO) Merit Award twice for his work in cancer genetics and translational research.
- Academic and Teaching Excellence: Former Assistant Professor at the Carver College of Medicine, University of Iowa, and a three-time recipient of the Best Teaching Award at Sheikh Khalifa Medical City (SKMC).
- Comprehensive Paediatric Cancer Care: Experienced in treating leukaemia, lymphoma, solid tumours, blood disorders, and caring for children undergoing bone marrow transplantation.
- ASCO Merit Award (Two-Time Winner) – Awarded by the American Society of Clinical Oncology for the best translational medicine research abstract in cancer genetics.
- Lymphoma Spore Group Grant Award (2005) – Granted for his pioneering work on DNA methylation in B-cell lymphomas.
- Best Teaching Award (Three-Time Winner) – Awarded by the Education Department at Sheikh Khalifa Medical City (SKMC).
- Employee of the Month – Sheikh Khalifa Medical City (SKMC).
Papers Published
- Pediatric allogeneic stem cell transplant outcomes in the United Arab Emirates (2009-2023): A multi-center report of survival and GVHD outcomes (ResearchGate, 2026)
+ Read More- Show Less
- High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching (International Journal of Hematology-Oncology and Stem Cell Research, 2025)
- Long-term outcomes and GVHD in patients receiving hematopoietic cell transplants abroad: A 14-year UAE multi-center cohort (medRxiv, 2024/2025)
- Trends and Demographics of Stem Cell Transplantation in the United Arab Emirates: A Retrospective Analysis from Three Major Tertiary Care Hospitals (2009-2023) (2024/2025)
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Paediatric Hematologist In Dubai



Dr. Neda Ashayeri

